Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines. [electronic resource]
Producer: 20121106Description: 431-40 p. digitalISSN:- 1532-7361
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Cetuximab
- Coculture Techniques
- Cytokines -- administration & dosage
- ErbB Receptors -- metabolism
- Flow Cytometry
- Head and Neck Neoplasms -- drug therapy
- Humans
- Immunologic Factors -- administration & dosage
- Interleukin-12 -- administration & dosage
- Killer Cells, Natural -- drug effects
- Mice
- Mice, Nude
- Squamous Cell Carcinoma of Head and Neck
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.